VR 102 (20 µg/day), Placebo vaginal ring without active drug, VR 102 (1 µg/day), VR 102 (10 µg/day) clinical trials

Investigation of 3 different doses of a newly developed vaginal ring releasing estriol for the treatment of vaginal atrophy - a placebo-controlled, double-blind, combined dose-finding and proof-of-concept trial with parallel-group design in postmenopausal women

This study is testing different doses of a new vaginal ring treatment for vaginal dryness and discomfort in women after menopause. It compares the ring with a dummy treatment to see which dose works best and if it helps improve vaginal health.